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Patient Reported Outcome Measure in a
randomised controlled trial of maternity
care
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Abstract
Background: Using patient-reported outcome measures (PROMs) to assess Quality of Life (QoL) is well established,
but commonly-used PROM item-sets do not necessarily capture what all respondents consider important. Measuring
complex constructs is particularly difficult in randomised controlled trials (RCTs). The Mother-Generated Index (MGI) is a
validated antenatal and postnatal QoL instrument in which the variables and scores are completely respondent-driven.
This paper reports on the feasibility and acceptability of the MGI in an RCT, and compares the resulting variables and
QoL scores with more commonly used instruments.
Methods: The single-page MGI was included at the end of a ten page questionnaire pack and posted to the RCT
participants at baseline (28–32 weeks’ gestation) and follow-up (six weeks postnatal). Feasibility and acceptability
were assessed by ease of administration, data entry and completion rates. Variables cited by women were analysed
thematically. MGI QoL scores were compared with outcomes from the EQ-5D-3 L; Edinburgh Postnatal Depression
Scale; Satisfaction With Life Scale; and State Trait Anxiety Inventory.
Results: Six hundred and seventy eight pregnant women returned the pack at baseline; 668 completed the MGI
(98.5 %); 383/400 returns at follow up included a completed MGI (95.7 %). Quantitative data were scanned into
SPSS using a standard data scanning system, and were largely error-free; qualitative data were entered manually.
The variables recorded by participants on the MGI forms incorporated many of those in the comparison instruments,
and other outcomes commonly used in intrapartum trials, but they also revealed a wider range of issues affecting their
quality of life. These included financial and work-related worries; moving house; and concerns over family illness and
pets. The MGI scores demonstrated low-to-moderate correlation with other tools (all r values p < .01).
Conclusions: Without face-to-face explanation and at the end of a long questionnaire, the MGI was feasible to use,
and acceptable to RCT participants. It allowed individual participants to include issues that were important to them,
but which are not well captured by existing tools. The MGI unites the explanatory power of qualitative research with
the comparative power of quantitative designs, is inexpensive to administer, and requires minimal linguistic and
conceptual translation.
Trial registration: ISRCTN27575146 (date assigned 23 March 2011)
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Background
In terms of health care research, and especially rando-
mised trials of effectiveness, death and serious morbidity
tend to be the default primary outcomes. It is clearly use-
ful to have common outcome measures so that data and
results can be compared, and the COMET initiative [1]
proposes the collection of core outcome sets within effect-
iveness trials. Within maternity care there is also a move
to encourage the use of ‘core’ outcome measures [2].
Nevertheless, studies have tended to cast their net widely
when deciding what to measure. Smith et al. [3] recent
systematic review of Cochrane reviews concerning intra-
partum studies identified 16 salutogenic (positive, health
generating) outcomes and 49 outcomes focused on patho-
logical phenomenon. A further recent study in the area of
preterm birth found that 72 outcome measures had been
used across 103 studies [4]. This divergence has led to a
call for the development of core outcome sets for research
across women’s health [2]. The proponents of this call rec-
ognise the need to include the perspectives of the women
who use these services.
The attempt to be inclusive and comprehensive is wel-
come, but unlikely to be straightforward when those de-
signing and funding RCTs tend to prioritise serious but
rare outcomes (such as mortality) over more complex
measures of experience and longer-term wellbeing that
might apply to more of those in the general populatio-
n—especially in maternity care where most women and
babies are healthy. One solution has been the inclusion
of patient-reported outcome measures (PROMs) to as-
sess Quality of Life (QoL) [5–7] [8]. PROMs were ori-
ginally developed to gauge the effectiveness of certain
surgical procedures [6]. More recently, they have been
expanded to a range of disciplines, in an attempt to “seek
to ascertain patients’ views of their symptoms, their func-
tional status, and their health-related quality of life” [9].
Despite the initial promise, it has been acknowledged
that the wide range of professionally-derived proformas
that are used to capture PROMs do not capture all the
factors that matter to health service users [6]. It is diffi-
cult to square the need for an agreed and parsimonious
core set for populations with particular health care needs,
while still capturing the large variation between individ-
uals within that population. The ideal instrument would
encompass the specific needs, wishes, and priorities of
each individual while at the same time providing a valid
and reliable objective measurement that is comparable
across populations and between studies. A validated QoL
tool in which the variables and scores are completely re-
spondent driven, but which could also provide a numeric
QoL score would have utility not only in the assessment
of clinical practice, but also as a key outcome measure in
RCTs. This paper reports on the feasibility and acceptabil-
ity of using one such tool, the Mother-Generated Index,
in a trial context, and compares the resulting variables and
QoL scores with more commonly used instruments.
The Mother-Generated Index (MGI)
The MGI was developed from the Patient-Generated
Index (PGI) [10] which has been used extensively, but
never in the context of an RCT [11]. The PGI was the
first attempt to develop a tool responsive to individual
patients’ particular experiences and concerns, and
which also converted those highly personal issues to a
single Quality of Life (QoL) score that could be com-
pared across populations. The MGI, in allowing indi-
vidual respondents to identify and then score and rank
the most important areas of their life, encourages this
subjective evaluation.
The MGI is a one-page three-step questionnaire which
generates a QoL score based on a list of variables that the
mother herself identifies as being important in the context
of the maternity care practice/intervention under examin-
ation. Because the variables the mother can record are not
pre-specified, the MGI does not lend itself to a standard
psychometric analysis [12], yet it has shown good face, cri-
terion and construct validity [13], and its feasibility, accep-
tibilty, reliability and validity as a measure of maternity
care in general have been established in observational and
before-and-after studies within several linguistic and cul-
tural groups in nine countries to date, and in both the
antenatal and postnatal periods [14–17]. In all the studies
to date participants were introduced to it during face to
face interviews, although one postal follow-up has also
been conducted [18].
In Step 1 of the MGI the woman records her subjective
description of what is important to her. Based on how she
has been affected over the previous month by these clin-
ical, emotional, cultural and psycho-social concerns she
then scores each area in Step 2 to produce a primary index
of quality of life (range 0 [worst] to 10 [optimum]). This
score, the average of the individual variable scores, can be
compared objectively across whole populations. In Step 3
she allocates ‘spending points’ to indicate the relative im-
portance of the areas she has cited. Figure 1 provides an
example of a completed MGI form.
We could not find any report of a completely
respondent-driven PROM such as this being used
within a trials context. We decided to include the MGI
in a pre-trial pilot of the SHIP trial [19]. Positive results
from this pilot convinced us to include it in the main
trial. We therefore set out to examine whether the MGI
was feasible and acceptable as a respondent-driven
PROM within a randomised controlled trial. We believe
this to be the first time that an individually patient-
generated postal PROM has been tested within the con-
text of an RCT.
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The context
The SHIP (Self-Hypnosis for Intrapartum Pain) trial took
place in seven sites across three NHS Trusts in the north-
west of England, including a range of birth settings (free
standing midwife led units, an alongside midwife led units,
and three hospitals with birth rates of 10,300, 6,900, and
4,500 in 2013). The Trusts covered both rural and urban
populations with a range of socio-demographic profiles.
The trial assessed the effect of a group-based antenatal
self-hypnosis education programme on rates of epidural
use in labour. Secondary outcomes included several mea-
sures of wellbeing and satisfaction using standard data
collection tools. The 680 participants were nulliparous
women not planning elective caesarean, without medica-
tion for hypertension and without psychological illness. A
ten-page questionnaire pack was sent by post to women
in both the intervention and control groups at baseline
(28–32 weeks), 36 weeks gestation, two weeks postnatally,
and six weeks postnatally. The MGI was included at the
end of the pack at baseline and six weeks postnatal.
Methods
Assessing feasibility and acceptibility of the MGI entailed
an examination of how well the tool could be integrated
into the questionnaire pack, how easily the data items
could be scanned with a standard data scanning system,
an assessment of the percentage of participants who
attempted the MGI even though it was at the end of a
long questionniare pack, and the average percentage of el-
ements of the instrument completed, and completed cor-
rectly at both time points. The validity of the MGI had
already been establised in a range of cultural contexts, so
formal validation was not required. However, a compari-
sion was made between the MGI QoL scores at both time
points, and the same woman’s scores for several psycho-
metric tools commonly used in maternity care service de-
velopment and research. Finally, to test the hypothesis
that a PROM based on what was important to each indi-
vidual trial participant would capture different variables
and concepts than commonly used tools in maternity care
trials, we examined these data thematically, and compared
them to the variables in the comparator tools in the SHIP
trial, and to the outcomes that were recorded in a re-
view of Cochrane reviews of intrapartum RCTs (Smith
et al. as above [3]).
Comparator instruments
Four of the measures in the questionnaire pack were ana-
lysed as comparators for the MGI. The EQ-5D-3L [20]
includes questions regarding mobility, self-care, usual
activities, pain/discomfort and anxiety/depression. The
Edinburgh Postnatal Depression Scale [21] is a widely-
used ten-question screening instrument that is validated
for both antenatal and postnatal use. The Satisfaction
With Life Scale [SWLS] [22] is a five-item instrument
measuring global cognitive judgements about life satisfac-
tion. The questions relate to whether life is ideal or not,
whether conditions are good, whether the respondent
has achieved most of the things they want to achieve or
would change things if they had the chance. The short
version of the State Trait Anxiety Inventory [STAI]
[23], a widely-used tool which measures anxiety, is said
to produce similar scores to the full version. Between
them, these instruments aimed to measure health sta-
tus, satisfaction with life, anxiety and depression.
Data entry
As part of the whole questionnaire pack, the completed
MGI results were scanned directly into the study database
for each respondent, and this was overseen by the Clinical
Trials Unit (CTU) associated with the study. The scanning
software identified numerical responses. Narrative re-
sponses were entered into the database by hand.
Analysis
Regular quality checks within the CTU tracked data entry
errors or unusual responses. Quantitative data from the
questionnaires were analysed in SPSS. Simple percentages
were used to determine completion rates. Simple correla-
tions using Pearson’s test were used to compare the MGI
QoL score and those on the comparator tools.
Each MGI form was also evaluated by a thematic ana-
lysis of the variables cited in Step 1; this was done inde-
pendently by paired members of the team. Disagreements
over themes were resolved at a team meeting. KF, AS and
RK independently generated themes from the narrative
data and matched the numeric data with the emergent
themes to produce frequencies as well as the primary and
secondary indices.
We then compared this analysis with the components
of these responses to the comparator tools and with the
outcomes identified by Smith et al. [3] in their system-
atic review of outcomes in the Cochrane Pregnancy and
Childbirth database.
Fig. 1 Example of completed MGI form
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Ethics approval was granted by an NHS IRAS Ethics
Committee and by the University of Central Lancashire,
Faculty of Health Ethics Committee. Formal written
consent was obtained from all participants before re-
cruitment to the study. This article presents independ-
ent research funded by the National Institute for
Health Research (NIHR) under its Research for Patient
Benefit (RfPB) Programme (Grant Reference Number
PB-PG-0808-16234). The views expressed are those of
the author(s) and not necessarily those of the NHS, the
NIHR or the Department of Health.
Results
The baseline survey at 28–32 weeks gestation was com-
pleted by 678/680 women (99.7 %), and 400 of these
678 completed the postal follow-up survey at 6 weeks
(59 %). Their socio-demographic data at baseline are
shown in Table 1. The socio-demographic characteris-
tics of those at follow-up were broadly similar across all
variables, the only exception being that those lost to at-
trition had slightly lower educational attainment (χ2 =
8.54; p < .05).
Feasibility of using the MGI within an RCT
The MGI took up one page in the ten page question-
niare pack and was easily integrated into theis. The
Clinical Trials Unit reported that the scoring for Steps
2 and 3 of the MGI was picked up well by the scanning
system they used, and that the data were largely free of
errors (see below for details). However, the narrative
data in the free text boxes (which described the vari-
ables of interest to each woman) had to be checked and
entered by hand.
Acceptability/ease of use
The percentage of questionnaire respondents who re-
corded at least some response on the MGI component
was 98.5 % (668/678) at baseline (338/342) [98.8 %]
intervention group and 330/336 [98.2 %] control group)
and 95.7 % (n = 383/400) at 6 weeks postnatal (200/207
[96.6 %] intervention group and 183/193 [94.8 %] con-
trol group). At baseline, 94.8 % (633/668) of respon-
dents listed the maximum number of five issues in Step
1 of the MGI with 20 citing four issues, nine citing
three, two citing two and four citing one. Completion
of the MGI Step 1 was also high at six weeks postna-
tally: 91.6 % (351/383) of participants listed five issues,
20 cited four, six wrote three, four listed two and two
cited one issue. All participants who completed a post-
natal MGI form had also completed the baseline MGI.
All participants at both time points were able to allo-
cate a score at Step 2 of the MGI but 21.4 % (142/662)
of participants at baseline and 27.6 % (103/383) of
women six weeks postnatally did not allocate the Step 3
points correctly. These inaccuracies were largely due
to using more or fewer than the 12 permitted points
or not allocating any points at all. As the calculation
of the QoL measure does not depend on Step 3 of
the MGI, this did not affect the capacity of the in-
strument to measure QoL quantiatively. With face-to-
face surveys any difficulties with form completion can
be overcome; improving the instructions for Step 3
completion in future postal surveys should mitigate
this problem.
Comparison with other instruments
The descriptive statistics for the various question-
naires are shown in Table 2. At baseline and postnatal
follow-up the MGI showed statistically significant
low-to-moderate correlations with all of the standard
questionnaires. The lowest correlations were recorded
against the EQ-5D. At baseline 64 % (426/662) women
scored ‘1’ (indicating perfect quality of life) on the
EQ-5D; at follow-up (6 weeks postnatal) 60 % did so
(239/385). This suggests that the EQ-5D has very low
discriminatory power for antenatal and postnatal
women, who are largely healthy.
Table 1 Socio-demographic characteristics of participants at baseline
Variable Total Intervention Control
N n Mean SD n Mean SD
Age 672 337 28.4 5.5 335 28.5 5.2
Gestation at randomization 669 335 27.8 1.0 334 27.8 1.1
N n n of event % n n of event %
Education (% GCSE or below) 665 333 70 21.0 332 54 16.3
Ethnicity (% White) 670 336 320 95.2 334 303 90.7
BMI > 40 (% at booking) 672 337 8 2.4 335 9 2.7
Income (% < £24,000 p/a) 652 324 99 30.6 328 89 27.1
Birth partner identified (% yes) 669 335 331 98.8 334 334 100.0
Type of Maternity Care (% midwife led) 655 327 287 87.8 328 288 87.8
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Comparing the reported issues in the MGI with those in
existing standard instruments and outcomes reported in
a systematic review of reviews of intrapartum
interventions
At baseline the 668 respondents cited a total of 3,280
comments in the MGI. In addition, both Step 2 scores
(reflecting how the woman had been affected by the
cited issue over the previous month; possible range 0-
10) and Step 3 scores (her relative ranking of import-
ance; possible range 0–12) varied considerably (Table 3).
The most commonly cited issues related to the woman’s
partner, extended family, career/work concerns, and her
own health and wellbeing. The woman’s wider social cir-
cle, issues regarding house and home, money, and the an-
ticipated baby, were important too, although several other
themes also emerged such as the transition to parenthood
and concern over illness within the family. These themes
partially echoed those variables included in standard
item-sets and Smith et al. [3] review of Cochrane re-
views, but there were many which stood apart from
these ‘standard’ outcomes.
Women who cited career and work issues gave them
varying scores. Low-scoring comments (“Completing work-
load before I leave”, “Stress at work” and “Returning to
Table 2 Standard psychometric measures: descriptive statistics and correlation with MGI
Correlation with MGI
Mean SD Range IQR r p
MGI Baseline 7.6 1.51 0–10 1.80 n/a
6 weeks PN 7.6 1.48 0–10 1.65 n/a
EQ-5D-3L Baseline .92 0.12 0.13–1 0.20 .225 p < .01
6 weeks PN .91 0.15 −.594–1 0.15 .226 p < .01
EPDS Baseline 6.4 4.53 0–26 6.00 −.350 p < .01
6 weeks PN 4.9 4.41 0–22 6.00 −.395 p < .01
SWLS Baseline 28.1 4.88 9–35 5.00 .464 p < .01
6 weeks PN 29.3 4.57 10–35 6.00 .334 p < .01
STAI Baseline 10.2 3.52 6–22 5.00 −.255 p < .01
6 weeks PN 9.3 3.42 0–23 5.00 −.306 p < .01
Key
IQR Interquartile Range, EQ-5D-3L Euroqol 5D [3L version], EPDS Edinburgh Postnatal Depression Scale, SWLS Satisfaction With Life Scale, STAI State Trait Anxiety
Inventory, 6 weeks PN 6 weeks postnatal
Table 3 Frequency of cited comments at baseline (27 weeks gestation), with associated MGI scores
Step 2 scores Step 3 scores
Comments Mean SD Range Mean SD Range
Partner 653 8.3 1.9 0–10 2.4 2.2 0–12
Extended family 550 8.2 2.2 0–10 2.5 2.4 0–12
Career/work 468 6.3 2.2 0–10 3.2 2.5 0–12
Health/Wellbeing (Self) 314 7.5 2.4 0–10 2.9 2.2 0–12
Friends 277 7.6 2.0 0–10 2.5 2.0 0–12
House/Home issues 219 8.4 2.3 1–10 2.6 2.3 0–12
Money 195 5.6 2.1 0–10 3.7 2.4 0–12
Baby 186 8.7 1.8 0–10 3.1 2.4 0–12
Transition: Preparation &
Planning
147 8.2 1.8 3–10 2.9 2.3 0–12
Becoming a Mother/Family 65 9.0 1.7 2–10 2.4 2.3 0–12
Education 39 6.6 2.4 2–10 2.8 2.0 0–10
Health/Wellbeing (Others) 34 6.2 3.0 0–10 5.0 3.8 1–12
Animals/Pets 33 7.6 3.2 0–10 2.9 3.2 0–12
Labour & Childbirth 22 4.7 3.1 1–10 4.2 3.2 1–12
Faith/religion 13 8.5 1.9 5–10 5.2 3.3 2–12
Other 65 6.6 2.7 0–10 3.3 3.0 0–12
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work after maternity leave”) were balanced by more posi-
tively worded ones (“Good working relationships”, and “Be-
ing in a stable job and financially secure”). Money issues
were commonly expressed, and these were mostly negative
(“Feeling isolated and lonely due to money”, and “Not hav-
ing enough money to get married or get a mortgage”).
Many found themselves wanting or having to move house
(“Finding a house”; “Getting a fixed address”) or preparing
the home (“Getting the house ready for baby”). Less ex-
pected areas included concern over a friend whose baby
had been born disabled, references to animals (“My pet cat
being stressed at changes”; “My dog has cancer”), to hob-
bies and to faith and religion.
The 1,861 comments cited by 383 mothers at postnatal
follow-up were categorised thematically, and the Step 2
and Step 3 scores analysed as before (Table 4).
As with the baseline comments these varied consid-
erably. Most postnatal comments fell into fairly pre-
dictable categories, reflecting outcomes measured in
other studies: joy or concern about the baby, relation-
ship with partner and parents, personal health and
wellbeing, and finding (or not finding) a routine or
new social circle. This compares with Smith et al. [3]
review which identified (albeit in very small numbers)
‘Positive relationship with infant’, ‘Wellbeing’ (her own
and the partner’s), and ‘Views’ (again her own and
her partner’s).
However, the MGI identified some complexity in these
issues, reflecting personal difficulties or sadness (“Rela-
tionship with baby’s father”; “Best friends leaving the
area”; “Remembering my dad”). Several commented on
the lack of ‘Me time’ (i.e. time to herself ). While some
comments expressed the happiness of the new or chan-
ging role (“Being a good mum”; “Making new friends
through baby groups”; “Being able to socialise and drink
again”), others revealed traumas (“Feeling out of control
[unable to plan day/night due to feeding demands]”).
One mother who cited “Post-traumatic stress brought
on by nightmares due to care whilst in labour” did in-
deed have a higher than average STAI score. For some,
other issues were important: one referred to starting her
own business, and another to having to learn a script for
a play. Religion (“Faith in God – Christianity”) and ani-
mals (“Exercising and bonding with dog”; “Making time
for my two cats”; “My horses”) featured again.
Discussion
This paper evaluates the incorporation of the MGI, a
respondent-driven Patient-Reported Outcome Measure,
as a postal QoL instrument within a randomised con-
trolled trial of self-hypnosis for labour pain amongst nul-
liparous women who were unselected for risk. We found
the incorporation of the MGI to be feasible, acceptable
and informative. Although the women had not seen the
MGI beforehand, completion rates were encouragingly
high at both baseline and follow-up, despite the fact that
it was the last questionnaire within a ten-page study
pack, and presumably the last to be completed. The high
response rate and the generally accurate form comple-
tion indicate that this respondent-driven instrument is
an acceptable way of determining quality of life as a trial
outcome, but based authentically on what matters to
each individual participant. Although the MGI only had
low to moderate correlation with a range of instruments
Table 4 Frequency of cited comments at baseline (6 weeks post-natal), with associated MGI scores
Step 2 scores Step 3 scores
Comments Mean SD Range Mean SD Range
Partner 364 8.4 1.8 0–10 2.7 2.0 0–12
Baby 296 9.0 1.7 2–10 2.4 2.4 0–12
Extended Family 267 8.5 1.7 0–10 2.2 2.2 0–10
Friends 189 7.1 2.0 2–10 2.5 1.7 0–9
Career/Work 144 5.8 2.4 0–10 3.1 2.4 0–12
Becoming a Mother/Family 142 8.9 1.4 3–10 2.6 2.1 0–11
Health/Wellbeing (Self) 137 6.2 2.5 0–10 3.5 2.4 0–12
House/Home Issues 124 6.6 2.1 0–10 3.1 2.5 0–12
Money 102 5.7 2.1 1–10 4.1 2.5 0–12
Transition: Preparation & Planning 23 6.5 2.4 1–10 3.1 1.8 1–6
Animals/Pets 16 7.0 2.9 0–10 3.3 2.6 0–9
Education 12 5.2 2.7 1–10 5.2 3.7 1–12
Health/Wellbeing (Others) 7 4.9 2.2 2–8 4.7 3.7 1–12
Faith/Religion 5 8.4 1.4 7–10 3.8 1.9 2–7
Other 33 6.2 3.2 0–10 3.4 2.8 1–12
Symon et al. BMC Medical Research Methodology  (2015) 15:100 Page 6 of 9
that are frequently used in maternity trials, we would
suggest that this might be because the MGI is better at
tapping issues that really matter to the individuals in the
study, in contrast to the fixed variable sets in the existing
tools. While some of the themes identified at baseline
and follow-up were to be expected (‘partner’, ‘baby’, ‘ex-
tended family’ ‘work’, ‘house and home’), others were less
predictable. The MGI allowed the women to raise issues
like education, the health and wellbeing of significant
others, financial issues and even pets and religion. In
addition, they were able to score and rank these. These
are aspects of their lives that most standard tools will
not cover.
An additional added value of the MGI is that it re-
quires minimal conceptual and linguistic translation if
it is just used as a measure of QoL. In this case, the var-
iables recorded by the participants do not need to be
translated, as what is of interest is the final numeric
score. The instructions are brief and easily translated.
The successful use of the MGI in a wide range of con-
text, including India [15] Germany [16] Poland [24]
and Iran [14] demonstrates its utility as an outcome
measure that can transcend language and cultural bar-
riers with relative ease. This is a significant advantage
for international multicentre studies and also for stud-
ies in a single country that include a wide range of cul-
tural and language groups, as is often the case for those
accessing maternity care.
Strengths and weaknesses of the study
The main strength of this study is that it was undertaken
alongside a robust clinical trial with a very high response
rate at baseline. While the trial did experience much
lower responses at the six week follow up, this was no
different for the MGI than for the other tools in the
questionnaire package, and, at both time points very
high percentages of respondents completed the MGI.
Limitations included variation in handwriting in self-
completed forms, which made electronic scanning of
free text entries problematic. As a consequence, manual
entry of comments was required. The fact that around
one in five respondents did not complete Step 3 of the
instrument correctly suggests that another limitation
was a lack of clear instructions as to how to undertake
this element of the tool. The order in which the various
instruments were offered in the questionnaire pack may
have affected what was cited in the MGI. Given that the
tool depends on women to report what matters to them,
it may be best to place it at the beginning of the pack, so
that the items in the other instruments do not influence
maternal responses. In fact, however, while some of the
comments identified by participants reflected domains
present in standard psychometric tools, many did not, so
order of questionnaire completion did not seem to influ-
ence the MGI responses in this study.
Strengths and weaknesses in relation to other studies
To our knowledge no previous RCT has included an
individualised respondent-driven PROM such as this, al-
though many studies have used health status or specific
quality of life instruments. Basing quality of life assess-
ment on the areas of life which the mother considers to
be those most important to her avoids the pitfalls of a
‘top-down’ instrument which, however well prepared,
may not reflect the woman’s current concerns [25]. Most
of the women in this study cited partner or other family
members as important considerations, yet, these vari-
ables are not usually included in the assessment of intra-
partum outcomes in controlled trials in maternity care
[3] and nor are they an element of the EQ-5D, STAI
short version or the SWLS. The EPDS, a screening tool
for maternal psychological wellbeing, does not even
mention the baby, a factor in the new mother’s life that
was worthy of note to almost all the mothers surveyed
here. Other factors not covered by the standard tools
but recorded as important by the respondents to this
study included financial worries, the stress of moving
house, anxiety concerning work or education, and the
importance of friends.
Satisfaction is commonly used as an indicator of patient
experience, but this approach has been criticised because
of a lack of standardisation and of reliability data [26]. The
link between patient satisfaction and the health care sys-
tem or health care quality and outcomes has been claimed
to be unclear and even tenuous [27, 28]. In condition-
specific cases a targeted quality of life evaluation may be
required (e.g. [29]). However, the experience of pregnancy
and new motherhood cannot be described as neatly as
with a specific medical condition, and the MGI allows a
holistic approach to be adopted that goes beyond satisfac-
tion measures. The MGI has been used in the UK,
Poland, Portugal, Brazil, Iran, China, India Germany
and Switzerland [14–17, 24]. Given the very limited
textual and conceptual translation that is needed for
the data collection tool, the MGI in most cases is easily
transferable into the full range of cultural and linguistic
contexts in which maternity care is provided. Other
tools, by contrast, often require sophisticated and ex-
pensive conceptual and linguistic fine-tuning to fit each
context in which they are used.
Many tools are available in a range wide of languages,
but this ease of use has potential pitfalls: if researchers as-
sume they are measuring one construct when they are
measuring another, then false inferences may be made.
The EQ-5D, for example, has been referred to as a ‘quality
of life’ tool [30, 31], although properly speaking it measures
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health status. Choice of tool must be informed by a clear
understanding of what is being assessed.
Implications for clinicians and policymakers
The MGI is already recognised as a valuable tool for
assessing women’s views and experiences of maternity
care in general. Extending it as a key outcome measure
for clinical trials would enable researchers to capture
complex and nuanced variations in what matters to
women. A QoL tool that allows scores to be compared
numerically between intervention and control groups,
and which also allows for more nuanced analysis of the
issues that affected women in relation to the trial, adds
a valuable extra layer of understanding. This can also
be used as a basis for understanding the contextual fac-
tors that might influence the success or failure of the
introduction of complex interventions into trials, open-
ing up what has been called the ‘black box’ of the
mechanisms of effect in such interventions [32]. These
added insights might also enable more efficient transfer
of knowledge from research to practice, as they could
frame the way in which an intervention should be im-
plemented if it is successful.
Unanswered questions and future research
The potential for the MGI to explain mechanisms of
effect of interventions in trials, and for this to inform
roll-out, needs to be assessed in future research. We
would recommend that the MGI is tested further in
future controlled studies of maternity care, and that
the Patient-Generated Index is also considered for use
in controlled trials in studies of health care in general.
Apart from one postal follow-up, prior to the SHIP
Trial the MGI had only been completed under the
supervision or guidance of a researcher. However,
given the excellent completion rates in this study there
would appear to be scope to test the distribution of the
tool on a variety of platforms including internet and
mobile devices.
The timing of the MGI’s application is an issue: it has
been used in various studies from the late pregnancy to
the immediate postnatal period and up to eight months
following the baby’s birth. Since quality of life is dy-
namic, it will clearly identify different issues at different
times. Large-scale longitudinal studies, including RCTs,
would allow for the tracking of changing issues of con-
cern and possible changing quality of life scores as well.
Given the prominence of comments relating to partners
in the SHIP study, and the known importance of social
support during and after pregnancy [33, 34], it would be
instructive to examine the quality of life of women and
partners as dyads.
Conclusion
With greater demographic and workforce mobility there
is increasing diversity within local populations; this com-
plexity is a factor of modern contemporary health care
and research. While Black [9] draws a distinction be-
tween PROMs and patient-reported experience mea-
sures (PREMs), in practice it may be difficult to separate
out a patient’s perceptions of a clinical condition and
their reported experience of clinical care related to this.
We have demonstrated that the MGI is a feasible, ac-
ceptable, and value-added quality of life measure for as-
sessment of outcome at two points in time in trials of
maternity care. It unites the explanatory power of quali-
tative research with the comparative power of quantita-
tive designs, is inexpensive to administer (and would be
even on a range of platforms) and, based on previous
studies, it is easily translated to a range of cultural and
linguistic contexts.
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